Field Trip Health Ltd (OTCQX: FTRPF) closed the last session at $5.1815, an increase of 12.64% that brought the company’s market cap to $296.92M. A recent trading volume of 282.58K shares of Field Trip Health stock was higher than its average daily volume of 55.51K. There are 57.30M outstanding shares of FTRPF stock versus a 17.62M float for the pink sheets company. FTRPF stock rose after the company became eligible for DTC in the United States.
What is DTC status?
Psychedelic therapies developed and delivered by Field Trip are among the world’s leading psychedelic therapies. The Field Trip Discovery division of FTRPF focuses on developing the next generation of psychedelic molecules, including plant-based psychedelics that produce psilocybin.
As part of FTRPF, Field Trip Health develops psychedelic therapy centers across North America and Europe, as well as the digital and technological tools that enable massive scale. These divisions offer a simple, evidence-based approach to healing and accelerated personal growth for people in treatment and those seeking accelerated growth.
Field Trip Health announced last week that its common shares will now be cleared and settled electronically through The Depository Trust Company (“DTC”) in the United States. As an affiliate of The Depository Trust & Clearing Corporation, DTC manages the electronic clearing and settlement of publicly traded companies.
What DTC means for FTRPF?
Field Trip Health (FTRPF) stock will be eligible to be cleared electronically, increasing the rate of reimbursement and enabling investors and brokers to trade the FTRPF stock more widely among brokerage firms.